Skip to main content

and
  1. No Access

    Article

    Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

    To evaluate the oncological impact of postponing radical cystectomy (RC) to allow further conservative therapies prior to progression in a large multicentre retrospective cohort of T1-HG/G3 patients initially ...

    Francesco Soria, Francesca Pisano, Paolo Gontero, J. Palou in World Journal of Urology (2018)

  2. No Access

    Article

    Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

    The goals of transurethral resection of a bladder tumor (TUR) are to completely resect the lesions and to make a correct diagnosis to adequately stage and treat the patient. Persistent disease after TUR is not...

    J. Palou, F. Pisano, R. Sylvester, S. Joniau, V. Serretta in World Journal of Urology (2018)

  3. No Access

    Article

    Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy

    The aim of the study was to identify the appropriate level of Charlson comorbidity index (CCI) in older patients (>70 years) with high-risk prostate cancer (PCa) to achieve survival benefit following radical p...

    A. Sivaraman, G. Ordaz Jurado, X. Cathelineau, Eric Barret in World Journal of Urology (2016)

  4. No Access

    Article

    Die postoperative Prognose des chromophoben Nierenzellkarzinoms

    Der chromophobe Subtyp (chNZK) stellt die dritthäufigste histologische Variante des Nierenzellkarzinoms (NZK) dar. Aufgrund der relativen Seltenheit dieses Subtyps liegt derzeit nur eine Arbeit vor, die eine g...

    Dr. M. May, R. Zigeuner, A. Aziz, L. Cindolo, C. Gilfrich, L. Schips in Der Urologe (2014)